U.S. flag

An official website of the United States government

NM_000642.3(AGL):c.1423+10T>C AND Glycogen storage disease type III

Germline classification:
Likely benign (1 submission)
Last evaluated:
Mar 27, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003635271.2

Allele description [Variation Report for NM_000642.3(AGL):c.1423+10T>C]

NM_000642.3(AGL):c.1423+10T>C

Gene:
AGL:amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p21.2
Genomic location:
Preferred name:
NM_000642.3(AGL):c.1423+10T>C
HGVS:
  • NC_000001.11:g.99876607T>C
  • NG_012865.1:g.31524T>C
  • NM_000028.3:c.1423+10T>C
  • NM_000642.3:c.1423+10T>CMANE SELECT
  • NM_000643.3:c.1423+10T>C
  • NM_000644.3:c.1423+10T>C
  • NM_000646.3:c.1375+10T>C
  • NM_001425325.1:c.1423+10T>C
  • NM_001425326.1:c.1423+10T>C
  • NM_001425327.1:c.1222+10T>C
  • NM_001425328.1:c.1219+10T>C
  • NM_001425329.1:c.1219+10T>C
  • NM_001425332.1:c.1045+10T>C
  • NC_000001.10:g.100342163T>C
Molecular consequence:
  • NM_000028.3:c.1423+10T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000642.3:c.1423+10T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000643.3:c.1423+10T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000644.3:c.1423+10T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000646.3:c.1375+10T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001425325.1:c.1423+10T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001425326.1:c.1423+10T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001425327.1:c.1222+10T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001425328.1:c.1219+10T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001425329.1:c.1219+10T>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001425332.1:c.1045+10T>C - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Glycogen storage disease type III (GSD3)
Synonyms:
Glycogen storage disease type 3; Forbes disease; Cori disease; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009291; MedGen: C0017922; Orphanet: 366; OMIM: 232400

Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...

    Assertion and evidence details

    Submission AccessionSubmitterReview Status
    (Assertion method)
    Clinical Significance
    (Last evaluated)
    OriginMethodCitations
    SCV004448927Labcorp Genetics (formerly Invitae), Labcorp
    criteria provided, single submitter

    (Invitae Variant Classification Sherloc (09022015))
    Likely benign
    (Mar 27, 2023)
    germlineclinical testing

    PubMed (1)
    [See all records that cite this PMID]

    Summary from all submissions

    EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
    not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

    Citations

    PubMed

    Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

    Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

    Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

    PubMed [citation]
    PMID:
    28492532
    PMCID:
    PMC5632818

    Details of each submission

    From Labcorp Genetics (formerly Invitae), Labcorp, SCV004448927.1

    #EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
    1not providednot providednot providednot providedclinical testing PubMed (1)
    #SampleMethodObservation
    OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
    1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

    Last Updated: Sep 29, 2024